Stock Market News for June 8, 2026
562 news published.
Big Pharma & biotech — trials, approvals and clinical catalysts
Merck (MRK) and Gilead reported positive topline results from two Phase 3 studies of an oral once‑weekly HIV regimen (islatravir/lenacapavir), and provided an additional update on KEYNOTE‑D46/EVOKE‑03. Favorable Phase 3 data can reshape market outlooks for HIV treatment and alter competitive positioning among long‑acting oral regimens.
Galmed Pharmaceuticals (GLMD) agreed to acquire Colospan, creating a GI‑focused platform targeting a $6 billion market and aiming to accelerate commercial scale if regulatory paths align.
Vor Bio / Telitacicept (VOR) logged conditional NMPA approval for IgA nephropathy and a separate nod in Sjögren’s disease, expanding addressable populations and shortening time to revenue in Greater China.
iPS Cell Sciences (IPSC) released ADA 2026 preclinical data for CNTY‑813 showing durable glucose control, immune evasion under alloimmune pressure and scalable manufacturing — key signals for cell‑therapy investors watching translational risk.
MetaVia (MTVA) presented late‑breaking obesity and metabolic data for DA‑1726 at ADA 2026, a datapoint investors watch in the competitive cardiometabolic space.
Corporate deals & financing — capital raises, debt and balance‑sheet moves
Tango Therapeutics (TNGX) announced a proposed $500 million public offering, a sizable equity raise that could fund late‑stage programs but will dilute existing shareholders if completed.
IDEAYA (IDYA) revealed a proposed public offering of common stock and pre‑funded warrants (details), another biotech capital move that may recalibrate runway and R&D pacing.
FSK (FSK) completed a public offering of $900 million 7.500% unsecured notes due 2031, a large cash infusion that shifts leverage profiles and funds near‑term strategy for the issuer.
Momentus (MNTS) added $76 million in cash, easing near‑term funding risk for the aerospace small cap as it advances commercial test flights.
Cerus Corporation (CERS) closed a new debt facility up to $110 million, extending runway for commercialization and blood‑safety operations.
FICO (FICO) unveiled a multi‑pronged capital plan—stock repurchases, an additional term loan and an accelerated program (read)—a mix that shifts leverage and cash allocation dynamics investors should watch.
Semiconductors, AI infrastructure and energy tech — partnerships and capacity
Cadence (CDNS) announced a collaboration with Intel Foundry to accelerate process optimization for Intel 14A targeting HPC and mobile designs. That ties EDA tools directly to foundry road maps and could speed time‑to‑market for next‑gen chips.
Applied Digital (APLD) signed a 210 MW lease at Delta Forge 2, expanding its AI factory franchise to a fifth campus and signaling continued appetite for hyperscale capacity.
STAK Inc. (STAK) plans to launch an AI‑ready distributed power solutions business through a proposed U.S. subsidiary (details), reflecting demand for edge power and resiliency in compute‑heavy deployments.
Broadcom (AVGO) expanded investment in Spring and the Java ecosystem to harden enterprise customers against AI‑enabled threats (read), linking infrastructure software with security priorities.
Factorial (FAC) listed on Nasdaq to commercialize solid‑state battery tech (details), a signal for progress toward manufacturable, higher‑energy‑density cells.
Consumer, travel and industrial — results and strategic plans
Vail Resorts (MTN) reported third‑quarter fiscal 2026 results, issued updated fiscal 2026 guidance and released early season‑pass sales (read). Season‑pass demand and guidance will be key for leisure‑cyclical peers.
VinFast (VFS) reported global revenue up 42% year‑over‑year in Q1 2026 (read), highlighting topline momentum but also ongoing capital and production needs for the EV upstart.
Duluth Holdings (DLTH) mapped a plan to double EBITDA by 2028 under a new "Build to Last" strategy (details), a clear signal investors will watch for margin expansion and execution on retail initiatives.
Oil‑Dri (ODC) posted record third‑quarter revenues and strong earnings growth (details), a positive signal for commodity‑linked industrial margins and execution.
Fintech, payments and listings — partnerships and index moves
Pagaya (PGY) expanded a multi‑year partnership with Upgrade to grow point‑of‑sale loans (read more), a move that could lift originations and fee income if credit performance holds.
FEMSA / QED (FMX) drew investor attention as QED prepares to invest in FEMSA’s lending venture, signaling continued appetite for Latin American embedded finance opportunities.
Coeur Mining (CDE) will join the S&P MidCap 400 Index, a change that typically draws passive inflows and boosts trading liquidity for the miner.
Markets, index inclusions and indicators
Liquidia (LQDA) will be added to the S&P SmallCap 600® Index, likely attracting index‑tracker flows and improving liquidity.
Schwab (SCHW) reported its Trading Activity Index™ — the STAX score — rebounded in May, a micro‑measure of retail engagement that can affect market breadth and volume expectations.
Leadership, licenses and market signals
Clarivate (CLVT) named Simon Webster as president of its Intellectual Property segment, a leadership move that may shape strategy in a high‑margin business line.
Farmer Mac (AGM) announced the effective date for completion of its CEO succession, an operational shift investors watch for governance and strategy continuity.
Selected commercial wins and operational updates
- RedCloud (RCT) signed a major beverage client to scale RedAI in Lagos toward 100,000 retailers (details), accelerating emerging‑market GTM.
- BOS (BOSC) reported $7.1 million in orders from India and the U.S. in the first five months of 2026 (read), improving near‑term revenue visibility.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement